Pessary Market Analysis

Based on type, the market is segmented into ring, donut, gellhorn and other types. Ring segment dominates the market with a share of 51.6% in 2024.

• The dominance of the ring segment is attributed to its broad applicability across a wide patient population. Ring pessaries are effective for treating mild to moderate prolapse and stress urinary incontinence, making them suitable for many patients.
  
• Additionally, ring pessaries are lightweight and flexible, offering comfort and reducing irritation, which allows for long-term use. This has led to their widespread adoption. According to the American Academy of Family Physicians, incontinence ring pessaries are among the most commonly used devices for treating stress urinary incontinence.
  

Based on application, the pessary market is segmented into mild pelvic organ prolapse, stress urinary incontinence, severe pelvic organ prolapse, and other applications. Mild pelvic organ prolapse segment dominates the market with a share of 42.9% in 2024.

• Pessaries are commonly recommended by medical practitioners as a first-line treatment for mild pelvic organ prolapse. Their non-invasive nature, ease of use, and ability to delay or eliminate the need for surgical interventions make them the preferred option for many patients.
  
• Furthermore, women with mild pelvic organ prolapse prefer pessary therapy due to its cost-effectiveness compared to surgical treatments. A May 2024 study published by the British Medical Journal found that pessary therapy is a more affordable option than surgery due to its lower costs.
  

Based on end user, the pessary market is segmented into hospitals, ambulatory surgical centers, clinics, and other end users. The hospitals segment held a dominating share of 46.2% in the market in 2024.

• Hospitals are key facilities for diagnosing, treating, and managing pelvic floor disorders such as pelvic organ prolapse (POP) and stress urinary incontinence (SUI). Most pessary fittings, insertions, and follow-up procedures are conducted in hospitals.
  
• Additionally, hospitals offer both surgical and non-surgical pessary treatments, making them the go-to choice for a wide range of conditions, particularly for more severe cases of prolapse or stress urinary incontinence.
  

In 2024, the U.S. led the North American pessary market, generating a revenue of about USD 169.7 million.

• The high prevalence of pelvic disorders in the U.S. is driving the demand for pessaries as a non-invasive treatment option for women. According to the University of Chicago Medical Center, around 50% of women experience some form of prolapse, and more than 12% of American women may require surgery for it during their lifetime.
  
• Additionally, the increasing incidence of lifestyle-related disorders and obesity among women in the U.S. is further raising the risk of pelvic disorders. According to the Centers for Disease Control and Prevention, 42.1% of women aged 20 and above were obese in the U.S. by June 2021, driving the rising demand for pessary therapy.
  

The UK is set to see a robust expansion in its pessary market from 2025 to 2034.

• Growing awareness of non-invasive treatment options for pelvic disorders is fueling revenue growth in the UK’s market. Organizations such as the United Kingdom Continence Society (UKCS) are working to increase awareness of pessaries as a suitable treatment for pelvic disorders. In March 2021, UKCS announced the launch of UK Clinical Guidelines for best practices in the use of vaginal pessaries for pelvic organ prolapse.
  
• Furthermore, pessaries have become a common treatment for prolapse in NHS hospitals. According to a January 2024 study published by Manchester University, using pessaries could help the NHS save USD 715 per patient, lowering overall treatment costs for pelvic organ prolapse in the UK. As a result, the adoption of pessary therapy is growing, driving market expansion.
  

Japan's Pessary market is set for lucrative growth from 2025 to 2034.

• Japan has a highly developed healthcare system with advanced medical technology and skilled professionals, making it an ideal environment for the use of pessaries for pelvic disorders.
  
• The growing elderly population in Japan is contributing to an increase in pelvic disorder cases. According to the World Bank Group, approximately 30% of Japan's population was aged 65 or older in 2023. Older women are more prone to developing pelvic organ prolapse, driving the demand for minimally invasive treatments like pessaries.
  

Saudi Arabia's pessary market is expected to witness substantial growth during the forecast period.

• Saudi Arabia has invested heavily in its healthcare system, establishing advanced medical facilities, adopting modern technologies, and providing high-quality healthcare services. Public and private hospitals in the country offer specialized treatments like pessaries for pelvic disorders, positioning Saudi Arabia as a key market for these treatments in the Middle East and Africa.
  
• Pelvic disorders, including pelvic organ prolapse, are becoming more common in Saudi Arabia. This increase is attributed to factors such as higher obesity rates, reduced physical activity, and a growing elderly female population. A study published in January 2022 by the National Center for Biotechnology Information found that 60.2% of women in Riyadh, Saudi Arabia, had pelvic floor dysfunction. This high prevalence is driving strong demand for pessary therapy in the country.